Evidence map›Paper›PMID 30834167›Full record

ReviewInnovations in clinical neuroscience2018

Measurement-based Care in Psychiatry-Past, Present, and Future.

Ahmed Aboraya, Henry A Nasrallah, Daniel E Elswick, Elshazly Ahmed, Nevine Estephan, Dalia Aboraya, Seher Berzingi, Josleen Chumbers, Sara Berzingi, John Justice and 2 more

Abstract readReview
In one paragraph

Review in Innovations in clinical neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ahmed AborayaDr. Aboraya is Chief of Psychiatry at William R. Sharpe, Jr. Hospital, Clinical Professor of Psychiatry at West Virginia School of Osteopathic Medicine, and Adjunct Faculty with the School of Public Health West Virginia University, in Weston, West Virginia.
Henry A NasrallahDr. Aboraya is Chief of Psychiatry at William R. Sharpe, Jr. Hospital, Clinical Professor of Psychiatry at West Virginia School of Osteopathic Medicine, and Adjunct Faculty with the School of Public Health West Virginia University, in Weston, West Virginia.
Daniel E ElswickDr. Aboraya is Chief of Psychiatry at William R. Sharpe, Jr. Hospital, Clinical Professor of Psychiatry at West Virginia School of Osteopathic Medicine, and Adjunct Faculty with the School of Public Health West Virginia University, in Weston, West Virginia.
Elshazly AhmedDr. Aboraya is Chief of Psychiatry at William R. Sharpe, Jr. Hospital, Clinical Professor of Psychiatry at West Virginia School of Osteopathic Medicine, and Adjunct Faculty with the School of Public Health West Virginia University, in Weston, West Virginia.
Nevine EstephanDr. Aboraya is Chief of Psychiatry at William R. Sharpe, Jr. Hospital, Clinical Professor of Psychiatry at West Virginia School of Osteopathic Medicine, and Adjunct Faculty with the School of Public Health West Virginia University, in Weston, West Virginia.
Dalia AborayaDr. Aboraya is Chief of Psychiatry at William R. Sharpe, Jr. Hospital, Clinical Professor of Psychiatry at West Virginia School of Osteopathic Medicine, and Adjunct Faculty with the School of Public Health West Virginia University, in Weston, West Virginia.
Seher BerzingiDr. Aboraya is Chief of Psychiatry at William R. Sharpe, Jr. Hospital, Clinical Professor of Psychiatry at West Virginia School of Osteopathic Medicine, and Adjunct Faculty with the School of Public Health West Virginia University, in Weston, West Virginia.
Josleen ChumbersDr. Aboraya is Chief of Psychiatry at William R. Sharpe, Jr. Hospital, Clinical Professor of Psychiatry at West Virginia School of Osteopathic Medicine, and Adjunct Faculty with the School of Public Health West Virginia University, in Weston, West Virginia.
Sara BerzingiDr. Aboraya is Chief of Psychiatry at William R. Sharpe, Jr. Hospital, Clinical Professor of Psychiatry at West Virginia School of Osteopathic Medicine, and Adjunct Faculty with the School of Public Health West Virginia University, in Weston, West Virginia.
John JusticeDr. Aboraya is Chief of Psychiatry at William R. Sharpe, Jr. Hospital, Clinical Professor of Psychiatry at West Virginia School of Osteopathic Medicine, and Adjunct Faculty with the School of Public Health West Virginia University, in Weston, West Virginia.
Jawad ZafarDr. Aboraya is Chief of Psychiatry at William R. Sharpe, Jr. Hospital, Clinical Professor of Psychiatry at West Virginia School of Osteopathic Medicine, and Adjunct Faculty with the School of Public Health West Virginia University, in Weston, West Virginia.
Sheena DoharDr. Aboraya is Chief of Psychiatry at William R. Sharpe, Jr. Hospital, Clinical Professor of Psychiatry at West Virginia School of Osteopathic Medicine, and Adjunct Faculty with the School of Public Health West Virginia University, in Weston, West Virginia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The authors define measurement-based care (MBC) in psychiatry as the use of validated clinical measurement instruments to objectify the assessment, treatment, and clinical outcomes, including efficacy, safety, tolerability, functioning, and quality of life, in patients with psychiatric disorders. MBC includes two processes: routine assessments, such as measuring the severity of symptoms with rating scales, and the use of assessments in decision-making. MBC implementation was tested in the Texas Medication Algorithm Project and the German Algorithm Project and has been shown to improve patient outcomes. Even though more recent research has shown the many benefits of MBC compared to the usual care, MBC is still not the standard of care in psychiatric practice. This review article addresses the advantages of MBC, the barriers to implementing MBC in clinical practice, and the basic properties of MBC instruments. Recent developments in the 21st century that are expected to accelerate the adoption of MBC in clinical practice, including electronic health records, health information technology, and the development of the Standard for Clinicians' lnterview in Psychiatry (SCIP) as an MBC tool, will be reviewed. The authors recommend including MBC in psychiatry residency training to promote its use in future generations.

Indexed as

assessmentassessment toolclinical trialMeasurement-based care (MBC)outcomes measurespsychopathologyrating scalereliabilityStandard for Clinicians’ lnterview in Psychiatry (SCIP)validity

Identifiers

PMID30834167
PMCPMC6380611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.